Accenture PLC vs. OptimizeRx Corporation Common Stock
Accenture PLC and OptimizeRx Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ACN | OPRX | |
|---|---|---|
| Market Cap | $110.98 billion | $149.93 million |
| Revenue (TTM) | $73.10 billion | — |
| Net Income (TTM) | $7.79 billion | — |
ACN leads on 1 of 1 size & scale factors.
Valuation
| ACN | OPRX | |
|---|---|---|
| P/E Ratio | 14.80 | — |
| Price / Book | 3.36 | — |
| Price / Sales | 1.52 | — |
ACN and OPRX split the valuation factors evenly.
Profitability
| ACN | OPRX | |
|---|---|---|
| Net Margin | 10.66% | — |
| Return on Equity | 23.60% | — |
ACN and OPRX split the profitability factors evenly.
Dividend
| ACN | OPRX | |
|---|---|---|
| Dividend Yield | 3.52% | — |
| Payout Ratio | 52.08 | — |
ACN and OPRX split the dividend factors evenly.
Risk & Sentiment
| ACN | OPRX | |
|---|---|---|
| Short Interest | 1.16% | 0.00% |
OPRX leads on 1 of 1 risk & sentiment factors.
Dig deeper: ACN overview, ACN financials, OPRX overview, OPRX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.